Everett Harris & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,620
Closed -$955K 264
2019
Q3
$955K Hold
9,620
0.02% 131
2019
Q2
$889K Hold
9,620
0.02% 138
2019
Q1
$908K Hold
9,620
0.02% 133
2018
Q4
$617K Buy
9,620
+6,400
+199% +$472K 0.02% 146
2018
Q3
$288K Hold
3,220
0.01% 213
2018
Q2
$256K Hold
3,220
0.01% 217
2018
Q1
$287K Sell
3,220
-900
-22% -$86.4K 0.01% 208
2017
Q4
$430K Hold
4,120
0.01% 176
2017
Q3
$601K Hold
4,120
0.02% 153
2017
Q2
$535K Hold
4,120
0.02% 162
2017
Q1
$513K Hold
4,120
0.02% 164
2016
Q4
$477K Sell
4,120
-300
-7% -$33.4K 0.02% 166
2016
Q3
$462K Hold
4,420
0.02% 166
2016
Q2
$436K Hold
4,420
0.02% 172
2016
Q1
$442K Hold
4,420
0.02% 179
2015
Q4
$529K Hold
4,420
0.02% 168
2015
Q3
$478K Hold
4,420
0.02% 174
2015
Q2
$512K Hold
4,420
0.02% 172
2015
Q1
$510K Hold
4,420
0.02% 165
2014
Q4
$494K Sell
4,420
-390
-8% -$41.1K 0.02% 163
2014
Q3
$456K Hold
4,810
0.02% 166
2014
Q2
$413K Hold
4,810
0.02% 171
2014
Q1
$336K Sell
4,810
-400
-8% -$31.7K 0.01% 185
2013
Q4
$440K Hold
5,210
0.02% 155
2013
Q3
$402K Hold
5,210
0.02% 148
2013
Q2
$305K Buy
+5,210
New +$314K 0.01% 174

Other funds holding CELG

Everett Harris & Co's CELG Position: Q4 2019 in Review

Everett Harris & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,620 shares — an estimated $955K sold.

Everett Harris & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $955K in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Everett Harris & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Everett Harris & Co sold 9,620 Celgene Corp shares in Q4 2019, an estimated $955K.
  • Everett Harris & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Everett Harris & Co's Celgene Corp position peaked at $955K in Q3 2019.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Everett Harris & Co's 13F filing for Q4 2019, filed 27 Jan 2020.